قالب وردپرس درنا توس
Home / Business / Biogen’s treatment for Alzheimer’s is about to be approved. That does not cause stocks to be bought.

Biogen’s treatment for Alzheimer’s is about to be approved. That does not cause stocks to be bought.



Covid-19 is not the only disease that scientists are trying to cure right now. Investors were reminded of that last week when Biogen’s Alzheimer’s medicine received a boost from reviewers in the U.S. Food and Drug Administration, ahead of Friday’s meeting. outside experts. The panel of experts then voted – 10 to 0 – that the Biogen studies did not prove the drug’s effectiveness.

Investors should think twice before buying Biogen shares to go higher.

Biogen …


Source link